Web Exclusives

Nurse-Led vs Oncologist-Led Breast Cancer Follow-up Program: Early Feasibility Results of an Ongoing Study

Nurse-Led vs Oncologist-Led Breast Cancer Follow-up Program: Early Feasibility Results of an Ongoing Study

Early feasibility results are presented for a trial that evaluates whether standard-of-care follow-up for women with early-stage breast cancer can be replaced by a nurse-led intervention focusing on patient self-management.

Survey Demonstrates Relationship Between Symptom Burden, Medical Disability Leave Among Myeloproliferative Neoplasms

Survey Demonstrates Relationship Between Symptom Burden, Medical Disability Leave Among Myeloproliferative Neoplasms

A survey-based study investigated the relationship between symptom burden and incidence of medical disability leave among patients with MPNs.

A Review of Clinical Outcomes in Patients With Early-Stage Burkitt Lymphoma

A Review of Clinical Outcomes in Patients With Early-Stage Burkitt Lymphoma

Older age is associated with worse prognosis in patients with early-stage Burkitt lymphoma, according to study authors.

NIH Establishes Educational Program on Genomics, Genetics for Oncology Nurses

NIH Establishes Educational Program on Genomics, Genetics for Oncology Nurses

NIH sought to bridge the gap in oncology nurse training in genomics and genetics to improve patient education and assessment of related risk factors.

Less Diversity in PROM Systems Could Improve Assessing Their Practicality for Cancer Patients, Clinicians

Less Diversity in PROM Systems Could Improve Assessing Their Practicality for Cancer Patients, Clinicians

Researchers report that diversity in PROM systems leads to inconsistent results across a selection of 41 such systems, despite being able to identify their common features.

Sequential Immunotherapy, Targeted Therapy Linked to Cutaneous Adverse Events in Advanced Melanoma

Sequential Immunotherapy, Targeted Therapy Linked to Cutaneous Adverse Events in Advanced Melanoma

Results of a retrospective chart review of patients with BRAF-mutant metastatic melanoma receiving sequential treatment with immunotherapy and targeted therapy or vice versa are presented.

The Where and What of Physical Activities Programs for Children With Cancer

The Where and What of Physical Activities Programs for Children With Cancer

An international "environmental scan" sought to determine the number of physical activity programs tailored to improve overall health and quality of life for children with cancer.

Takeda to Collaborate With MSKCC on CAR-T Therapies for Multiple Myeloma

Takeda to Collaborate With MSKCC on CAR-T Therapies for Multiple Myeloma

Takeda will work with Memorial Sloan Kettering Cancer Center to develop CAR-T therapies for multiple myeloma.

Shorter Duration of Cryotherapy as Effective as Standard Therapy Prior to HSCT for Multiple Myeloma

Shorter Duration of Cryotherapy as Effective as Standard Therapy Prior to HSCT for Multiple Myeloma

This study sought to determine the noninferiority of 2 hours of cryotherapy vs standard 7 hours prior to high-dose melphalan before autologous HSCT.

Lymphoma Survivors Experience Special Needs During Transition to Survivorship Care

Lymphoma Survivors Experience Special Needs During Transition to Survivorship Care

A qualitative study revealed the unique needs of lymphoma survivors transitioning from active care to survivorship.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs